OTCMKTS:PBIO

Pressure BioSciences (PBIO) Stock Forecast, Price & News

$0.20

-0.01 (-4.76%)

(As of 09/28/2023 ET)

Compare

Today's Range: $0.18
▼
$0.22
50-Day Range: $0.19
▼
$0.50
52-Week Range: $0.18
▼
$2.20

Volume: 70,645 shs
Average Volume: 46,167 shs
Market Capitalization: $3.89 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Earnings Financials Headlines SEC Filings Short Interest

About Pressure BioSciences (OTCMKTS:PBIO) Stock

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.

PBIO Price History

30 days | 90 days | 365 days | Advanced Chart

PBIO Stock News Headlines

September 22, 2023 | finance.yahoo.com

Pressure BioSciences’ Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately

September 21, 2023 | finanznachrichten.de

Pressure BioSciences Inc.: Pressure BioSciences Fulfillment of UltraShear Nano-CBD Orders is Underway; Customer Shipments Begin First Week of October

September 28, 2023 | Porter and Company (Ad)

Elon Bets Big On Controversial Energy Tech: "This Is Bigger Than AI"

If this tech goes mainstream, it could destroy the oil and gas industry, the clean energy sector, and the billionaires who profit from it…

September 21, 2023 | bbc.com

Meditate to beat stress blood pressure, say guidelines

September 21, 2023 | americanbankingnews.com

Pressure BioSciences (OTCMKTS:PBIO) Stock Price Passes Below 200 Day Moving Average of $0.79

September 8, 2023 | finance.yahoo.com

Pressure BioSciences’ BaroFold Technology Achieves Pivotal Equipment Sale and Begins Scale-up in Service to Leading Global Contract Devt. & Mfg. Organization

August 30, 2023 | finance.yahoo.com

Pressure BioSciences Provides Second Progress Report on UltraShear Nano-CBD Launch and Commercialization Program "Drive to 420!"

August 22, 2023 | finance.yahoo.com

Pressure BioSciences, Inc. Reports Q2 2023 Financial Results, Provides Business Update, and Offers Guidance for 2nd Half 2023

September 28, 2023 | Chaikin Analytics (Ad)

This is the #1 Stock to Buy for the AI Tidal Wave

Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.

August 21, 2023 | investing.com

Pressure Biosciences (PBIO) Earnings Dates & Reports

August 17, 2023 | finance.yahoo.com

Pressure BioSciences Invites Interested Investors to Attend a Webinar on the Health and Wellness Marvels of PBIO's Revolutionary UltraShear Platform

August 11, 2023 | finance.yahoo.com

New to The Street Announces its Six Corporate Guests TV Interviews; Broadcastings on Newsmax and The FOX Business Network, Airings Start on Saturday, August 12, 2023, at 3:30 PM ET

August 9, 2023 | finanznachrichten.de

Pressure BioSciences Inc.: Pressure BioSciences Reports Strongly Accelerating UltraShear Nano-CBD Orders

August 9, 2023 | finance.yahoo.com

Pressure BioSciences Reports Strongly Accelerating UltraShear Nano-CBD Orders

July 27, 2023 | finance.yahoo.com

Pressure BioSciences and Master Distributor Canopy CBD Farms Announce Major Increase in UltraShear Nanoemulsion Platform Pipeline

July 25, 2023 | benzinga.com

CBD To Extend Shelf-Life Of Fresh Produce? This Company Is Working On It

July 25, 2023 | finance.yahoo.com

Pressure BioSciences Launches Program to Evaluate Company's Patented UltraShear Process in Breakthrough Application to Extend Shelf-Life of Fresh Produce

July 17, 2023 | finance.yahoo.com

Pressure BioSciences Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering

July 10, 2023 | finance.yahoo.com

Pressure BioSciences Announces UltraShear Processed Nano-CBD Topical Spray Distribution Agreement with Premier CA Cannabis Partner Crème de Canna

July 5, 2023 | finance.yahoo.com

Pressure BioSciences Announces Agreement with Somalab Int’l for Development & Distribution of UltraShear-Enabled Nanoemulsified Health and Wellness Products

June 27, 2023 | finance.yahoo.com

Third Round of Consumer Testing Strongly Validates Rapid Absorption and Effectiveness of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray

June 13, 2023 | finance.yahoo.com

Pressure BioSciences Partners with Veterans Service Team to Offer Exclusive Access for VST Members to a Unique, Custom-Made, UltraShear Nano-CBD & Other Products

June 2, 2023 | ca.finance.yahoo.com

New to The Street Signs Pressure BioSciences, Inc. To 12 Month TV Series, Agreement Includes Commercials and Billboard Ads

June 1, 2023 | finance.yahoo.com

New to The Street Signs Pressure BioSciences, Inc. To 12 Month TV Series, Agreement Includes Commercials and Billboard Ads

June 1, 2023 | finance.yahoo.com

Pressure BioSciences Updates Forecast with Six Key Goals for June 2023 with Expected Multi-Million Dollar Growth Increments in FY 2023 and Beyond

May 22, 2023 | finance.yahoo.com

Pressure BioSciences Announces Commercial Availability of Best-in-Class Nano-CBD Topical Spray, Featuring Lightning-Fast Action from PBI's UltraShear Processing

May 17, 2023 | marketwatch.com

InvestorNewsBreaks - Pressure BioSciences Inc. (PBIO) Achieves Record Financial Results in Q1 2023

See More Headlines

Receive PBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter.

PBIO Company Calendar

Last Earnings: 8/21/2023
Today: 9/28/2023
Next Earnings (Estimated): 11/20/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:PBIO
CUSIP: N/A
CIK: 830656
Web: www.pressurebiosciences.com
Phone: 508-230-1828
Fax: 508-230-1829
Employees: 16
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.84)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-16,080,000.00
Net Margins: -1,132.78%
Pretax Margin: -1,132.83%
Return on Equity: N/A
Return on Assets: -1,038.95%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.04
Quick Ratio: 0.02

Sales & Book Value

Annual Sales: $1.73 million
Price / Sales: 2.25
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($2.56) per share
Price / Book: -0.08

Miscellaneous

Outstanding Shares: 19,456,000
Free Float: 17,413,000
Market Cap: $3.89 million
Optionable: Not Optionable
Beta: 0.67

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Richard T. Schumacher (Age 73)
Founder, Pres, CEO, Treasurer, Interim CFO, Clerk & Director
Comp: $320.54k

Dr. Alexander V. Lazarev Ph.D. (Age 58)
Chief Science Officer
Comp: $202.27k

Dr. Edmund Y. Ting Ph.D. (Age 68)
Sc.D. Ph.D., Sr. VP of Engineering
Comp: $215.16k

John B. Hollister
Director of Sales & Marketing

Key Competitors

View All Competitors

PBIO Stock - Frequently Asked Questions

How have PBIO shares performed in 2023?: Pressure BioSciences' stock was trading at $1.30 at the beginning of 2023. Since then, PBIO shares have decreased by 84.6% and is now trading at $0.1999.
View the best growth stocks for 2023 here.
Are investors shorting Pressure BioSciences?: Pressure BioSciences saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 100 shares, a decline of 98.4% from the August 31st total of 6,200 shares. Based on an average daily trading volume, of 195,100 shares, the days-to-cover ratio is currently 0.0 days.
View Pressure BioSciences' Short Interest.
When is Pressure BioSciences' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 20th 2023.
View our PBIO earnings forecast.
How were Pressure BioSciences' earnings last quarter?: Pressure BioSciences, Inc. (OTCMKTS:PBIO) released its quarterly earnings results on Monday, August, 21st. The company reported ($0.57) earnings per share (EPS) for the quarter. The company earned $0.51 million during the quarter.

What other stocks do shareholders of Pressure BioSciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure BioSciences investors own include Advanced Micro Devices (AMD), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL), Aware (AWRE), Curaleaf (CURLF) and Walt Disney (DIS).
What is Pressure BioSciences' stock symbol?: Pressure BioSciences trades on the OTCMKTS under the ticker symbol "PBIO."
How do I buy shares of Pressure BioSciences?: Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Pressure BioSciences' stock price today?: One share of PBIO stock can currently be purchased for approximately $0.20.
How much money does Pressure BioSciences make?: Pressure BioSciences (OTCMKTS:PBIO) has a market capitalization of $3.89 million and generates $1.73 million in revenue each year. The company earns $-16,080,000.00 in net income (profit) each year or ($1.84) on an earnings per share basis.
How can I contact Pressure BioSciences?: Pressure BioSciences' mailing address is 14 NORFOLK AVENUE, SOUTH EASTON MA, 02375. The official website for the company is www.pressurebiosciences.com. The company can be reached via phone at 508-230-1828, via email at ir@pressurebiosciences.com, or via fax at 508-230-1829.

This page (OTCMKTS:PBIO) was last updated on 9/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial